What's in Greater Houston Retina Research's pipeline?

Greater Houston Retina Research has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Greater Houston Retina Research's portfolio?

Top competitors by shared drug class: AbbVie, Ain Shams University, Hoffmann-La Roche, LEANDRO CABRAL ZACHARIAS, Medical University of Vienna.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/greater-houston-retina-research.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Greater Houston Retina Research — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Greater Houston Retina Research pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Ranibizumab (Lucentis)	Ranibizumab (Lucentis)	marketed	VEGF-A inhibitor (monoclonal antibody fragment)	VEGF-A (Vascular Endothelial Growth Factor A)	Ophthalmology

Therapeutic area mix

Ophthalmology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie · 1 shared drug class
Ain Shams University · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
LEANDRO CABRAL ZACHARIAS · 1 shared drug class
Medical University of Vienna · 1 shared drug class
Retinal Consultants of Arizona · 1 shared drug class
Samsung Bioepis Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Greater Houston Retina Research:

Cite this brief

Drug Landscape (2026). Greater Houston Retina Research — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/greater-houston-retina-research. Accessed 2026-05-18.